cannabis indica

Índice completo — página 68 de 77

Estudos 6.701 a 6.800 de 7.640, ordenados do mais recente ao mais antigo — nesta página, publicações de 2009 a 2008. Para buscar por termo ou combinar filtros, use o acervo com busca.

Estudos 6.701 a 6.800

  1. 2009

    The endocannabinoid system as a target for the treatment of motor dysfunction

  2. 2009

    The endocannabinoid system during development: emphasis on perinatal events and delayed effects

    InconclusivoMetanáliseGestação2-Araquidonoilglicerol (2-AG)
  3. 2009

    The Endocannabinoid System Of The Skin In Health And Disease: Novel Perspectives And Therapeutic Opportunities

    FavorávelMetanáliseCâncerAcneDermatite de Contato Alérgica+8
  4. 2009

    The long and the short of treatments for alcohol or cannabis misuse among people with severe mental disorders

    DesfavorávelMetanálise ClínicaDependência QuímicaDependência — CannabisDepressão+2
  5. 2009

    The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisDepressão+1
  6. 2009

    The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD).

    FavorávelEnsaio ClínicoTEPTCanabinoide Sintético (não especificado)
  7. 2009

    Time-Dependent Vascular Effects of Endocannabinoids Mediated by Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)

  8. 2009

    Treatment of a hyperkinetic movement disorder during pregnancy with dronabinol.

  9. 2009

    Treatment of cannabis use disorders in people with schizophrenia spectrum disorders - a systematic review

    InconclusivoMetanálise ClínicaDependência QuímicaDependência — CannabisEsquizofrenia
  10. 2009

    Up-regulation of TRPV1 in mononuclear cells of end-stage kidney disease patients increases susceptibility to N-arachidonoyl-dopamine (NADA)-induced cell death

  11. 2009

    Ventricular tachycardia due to marijuana use in a heart transplant patient

  12. 2009

    Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review

    FavorávelMetanálise ClínicaEsclerose Múltipla
  13. 2009

    WIN55,212-2, a Cannabinoid Receptor Agonist, Protects Against Nigrostriatal Cell Loss in the MPTP Mouse Model of Parkinson’s Disease.

  14. 2009

    Withdrawal Phenomena and Dependence Syndrome After the Consumption of "Spice Gold"

  15. 2008

    A Comparative Study on Cannabidiol-Induced Apoptosis in Murine Thymocytes and EL-4 Thymoma Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Timo
  16. 2008

    A decrease in anandamide signaling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain

  17. 2008

    A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner

  18. 2008

    A Pilot Study of Perillyl Alcohol in Pancreatic Cancer

    FavorávelEnsaio ClínicoCâncerCâncer — Pâncreas
  19. 2008

    A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain.

  20. 2008

    Abnormalities in the cerebrospinal fluid levels of endocannabinoids in multiple sclerosis.

    FavorávelEnsaio ClínicoEsclerose MúltiplaAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+1
  21. 2008

    Adverse effects of medical cannabinoids: a systematic review

    DesfavorávelMetanálise ClínicaEfeitos Adversos da Cannabis
  22. 2008

    Analgesic and antihyperalgesic effects of nabilone on experimental heat pain

    InconclusivoEnsaio Clínico Duplo-CegoDorTHC Farmacêutico
  23. 2008

    Anandamide and Neutrophil Function in Patients With Fibromyalgia

    FavorávelMetanáliseEstresse OxidativoFibromialgiaAnandamida (AEA)
  24. 2008

    Anti-dyskinetic effects of cannabinoids in a rat model of Parkinson's disease: role of CB1 and TRPV1 receptors

    FavorávelEstudo em AnimaisDoença de ParkinsonAnandamida (AEA)Canabinoides Sintéticos WIN-x+1
  25. 2008

    Antibacterial Cannabinoids from Cannabis sativa: A Structure−Activity Study.

    FavorávelEstudo LaboratorialInfecção por EstafilococosTetraidrocanabinol (THC)Canabigerol (CBG)+2
  26. 2008

    Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay

    FavorávelEstudo LaboratorialCondições Geriátricas
  27. 2008

    Antiproliferative effects of essential oils and their major constituents in human renal adenocarcinoma and amelanotic melanoma cells.

    FavorávelEstudo LaboratorialCâncerCâncer — MelanomaCâncer — Rim
  28. 2008

    Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.

    FavorávelEstudo em AnimaisHepatiteAnandamida (AEA)Hidrolase de Amidas de Ácidos Graxos (FAAH)+4
  29. 2008

    Behavioral and Temperature Effects of Delta 9-tetrahydrocannabinol in Human-Relevant Doses in Rats

  30. 2008

    Beta-caryophyllene Is A Dietary Cannabinoid

    FavorávelEstudo em AnimaisDorDor — CrônicaDoenças Cardiovasculares (DCV)+2
  31. 2008

    Biological activities of Korean Citrus obovoides and Citrus natsudaidai essential oils against acne-inducing bacteria.

    FavorávelEstudo LaboratorialAcne
  32. 2008

    Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in mice.

  33. 2008

    Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma.

  34. 2008

    Cannabinoid modulation of amygdala reactivity to social signals of threat in humans

    FavorávelEnsaio Clínico Duplo-CegoAnsiedadeTEPT
  35. 2008

    Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial

  36. 2008

    Cannabinoid receptor-1 modulation induces apoptosis of human melanoma cells

  37. 2008

    Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice

  38. 2008

    Cannabinoids in Chronic Pain and Palliative Care

    FavorávelMetanáliseDorDor — CrônicaCuidados Paliativos
  39. 2008

    Cannabinoids in pancreatic cancer: Correlation with survival and pain

    FavorávelEstudo LaboratorialCâncerCâncer — PâncreasAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  40. 2008

    Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells

    FavorávelEstudo LaboratorialHIV/AIDS2-Araquidonoilglicerol (2-AG)Canabinoides Sintéticos AM-x+2
  41. 2008

    Cannabinoids Reduce Markers of Inflammation and Fibrosis in Pancreatic Stellate Cells.

    FavorávelEstudo LaboratorialPancreatiteAnandamida (AEA)2-Araquidonoilglicerol (2-AG)+2
  42. 2008

    Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation

    FavorávelMetanáliseSíndrome de Ativação Mastocitária
  43. 2008

    Cannabis and schizophrenia

    InconclusivoMetanálise ClínicaEsquizofrenia
  44. 2008

    Cannabis improves symptoms of ADHD

    FavorávelMetanáliseTDA e TDAHTHC Farmacêutico
  45. 2008

    Cannabis Smoking and Periodontal Disease Among Young Adults

    DesfavorávelMetanáliseDoença Periodontal
  46. 2008

    Cannabis use and cancer of the head and neck: Case-control study

    InconclusivoMetanáliseCâncerCâncer — Escamoso de Cabeça e Pescoço
  47. 2008

    CB2 receptors in reproduction

  48. 2008

    Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis

  49. 2008

    Clinical Endocannabinoid Deficiency (CECD): Can This Concept Explain Therapeutic Benefits of Cannabis in Migraine, Fibromyalgia, Irritable Bowel Syndrome and Other Treatment-Resistant Conditions?

  50. 2008

    Combination therapy with direct hemoperfusion using polymyxin B-immobilized fiber and oral vancomycin improves fulminant pseudomembranous colitis by reducing the elevated endogenous cannabinoids and inflammatory cytokines: report of a case

    FavorávelMetanáliseSepseAnandamida (AEA)Endocanabinoide (não especificado)+1
  51. 2008

    Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — Neuropatia PeriféricaTHC Farmacêutico
  52. 2008

    Complementary therapies for neuropathic and neuralgic pain: systematic review

    DesfavorávelMetanálise ClínicaDorDor — Neuropatia PeriféricaDor — Polineuropatia Inflamatória+2
  53. 2008

    Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review

    DesfavorávelMetanálise ClínicaObesidadeCanabinoides Sintéticos SR-x
  54. 2008

    Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia

  55. 2008

    Current Status of Cannabis Treatment of Multiple Sclerosis with an Illustrative Case Presentation of a Patient with MS, Complex Vocal Tics, Paroxysmal Dystonia, and Marijuana Dependence Treated with Dronabinol.

  56. 2008

    Degradation of endocannabinoids in chronic migraine and medication overuse headache

  57. 2008

    Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum.

    FavorávelEnsaio Clínico Duplo-CegoEsquizofreniaTetraidrocanabinol (THC)
  58. 2008

    Delta 9-tetrahydrocannabinol Inhibits Cell Cycle Progression By Downregulation Of E2F1 In Human Glioblastoma Multiforme Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Cérebro
  59. 2008

    Delta9-Tetrahydrocannabinol Inhibits Epithelial Growth Factor-induced Lung Cancer Cell Migration In Vitro As Well As Its Growth And Metastasis In Vivo

    FavorávelEstudo LaboratorialCâncerCâncer — PulmãoTetraidrocanabinol (THC)
  60. 2008

    Disruption of IFN-γ-Mediated Antiviral Activity in Neurons: The Role of Cannabinoids

    InconclusivoEstudo LaboratorialInflamaçãoDoenças PriônicasCanabinoides Sintéticos WIN-x
  61. 2008

    Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol.

  62. 2008

    Dual, time-dependent deleterious and protective effect of anandamide on the course of cerulein-induced acute pancreatitis. Role of sensory nerves.

    FavorávelEstudo em AnimaisPancreatiteAnandamida (AEA)
  63. 2008

    Early endothelial dysfunction as a marker of vasculogenic erectile dysfunction in young habitual cannabis users

    DesfavorávelMetanáliseLibidoDisfunção Erétil
  64. 2008

    Effect of cannabidiol on sepsis-induced motility disturbances in mice: involvement of CB receptors and fatty acid amide hydrolase.

  65. 2008

    Effect of cannabinoid receptor agonists on streptozotocin-induced hyperalgesia in diabetic neuropathy.

  66. 2008

    Effect of olanzapine and risperidone on subjective well-being and craving for cannabis in patients with schizophrenia or related disorders: a double-blind randomized controlled trial

    DesfavorávelEnsaio Clínico Duplo-CegoDependência QuímicaDependência — CannabisEsquizofrenia
  67. 2008

    Effect of rimonabant on the high-triglyceride/ low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial

    FavorávelEnsaio Clínico Duplo-CegoObesidadeCanabinoide Sintético (não especificado)
  68. 2008

    Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers

    DesfavorávelEnsaio ClínicoEsquizofreniaTetraidrocanabinol (THC)
  69. 2008

    Effects of cannabis use on outcomes of psychotic disorders: systematic review

    DesfavorávelMetanálise ClínicaPsicose
  70. 2008

    Effects of perinatal exposure to delta-9-tetrahydrocannabinol on the emotional reactivity of the offspring: a longitudinal behavioral study in Wistar rats

    DesfavorávelEstudo em AnimaisGestaçãoTranstornos de ComportamentoTetraidrocanabinol (THC)
  71. 2008

    Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse

    DesfavorávelEnsaio ClínicoDependência QuímicaDependência — CannabisTHC Farmacêutico
  72. 2008

    Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy

    FavorávelEnsaio Clínico Duplo-CegoDorDor — CrônicaTHC Farmacêutico
  73. 2008

    Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling.

    FavorávelEstudo LaboratorialAcneSeborreiaAnandamida (AEA)Endocanabinoide (não especificado)+2
  74. 2008

    Endocannabinoids in liver disease and hepatic encephalopathy

  75. 2008

    Endogenous cannabinoids contribute to remote ischemic preconditioning via cannabinoid CB2 receptors in the rat heart

  76. 2008

    Enhancing The In Vitro Cytotoxic Activity Of Delta9-tetrahydrocannabinol In Leukemic Cells Through A Combinatorial Approach

    FavorávelEstudo LaboratorialCâncerCâncer — LeucemiaTetraidrocanabinol (THC)
  77. 2008

    Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus.

    FavorávelMetanáliseNáusea e VômitoAnorexia (perda de apetite)Hepatite
  78. 2008

    Expression Of Cannabinoid Receptors Type 1 And Type 2 In Non-Hodgkin Lymphoma: Growth Inhibition By Receptor Activation

    FavorávelEstudo LaboratorialCâncerCâncer — LinfomaOutros Compostos Relacionados
  79. 2008

    Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis

  80. 2008

    Further characterisation of a rat model of varicella zoster virus (VZV)-associated pain

    FavorávelEstudo em AnimaisDorDor — Neuropatia PeriféricaHerpesCanabinoides Sintéticos WIN-x+1
  81. 2008

    Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET

  82. 2008

    Genetic And Pharmacological Manipulations Of The CB(1) Receptor Alter Ethanol Preference And Dependence In Ethanol Preferring And Nonpreferring Mice

  83. 2008

    Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome.

    FavorávelEstudo LaboratorialSíndrome de DownHidrolase de Amidas de Ácidos Graxos (FAAH)
  84. 2008

    Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system

  85. 2008

    Impaired cannabinoid receptor type 1 signaling interferes with stress-coping behavior in mice

    FavorávelEstudo em AnimaisCanabinoides Sintéticos SR-x
  86. 2008

    Improvement in refractory obsessive compulsive disorder with dronabinol

    FavorávelMetanáliseTOCTHC Farmacêutico
  87. 2008

    Influence of Cannabis Use on Suicidal Ideations Among 491 High-School Students

    InconclusivoMetanáliseTentativa de Suicídio
  88. 2008

    Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine

    FavorávelEstudo em AnimaisDieta
  89. 2008

    Influence of taranabant, an orally active, highly selective, potent cannabinoid-1 receptor (CB1R) inverse agonist, on ethinyl estradiol and norelgestromin plasma pharmacokinetics

    FavorávelEnsaio Clínico Duplo-CegoObesidadeGestaçãoCanabinoide Sintético (não especificado)
  90. 2008

    Inhaled linalool-induced sedation in mice.

    FavorávelEstudo em AnimaisAnsiedadeEpilepsiaInsônia e Distúrbios do Sono
  91. 2008

    Inhibition Of Cancer Cell Invasion By Cannabinoids Via Increased Expression Of Tissue Inhibitor Of Matrix Metalloproteinases-1

  92. 2008

    Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625

  93. 2008

    Inhibitory effect of synthetic cannabinoids on cytokine production in rheumatoid fibroblast-like synoviocytes

  94. 2008

    Invasive pulmonary aspergillosis associated with marijuana use in a man with colorectal cancer

    DesfavorávelMetanáliseInfecções Fúngicas
  95. 2008

    Is emotional intelligence impaired in ecstasy-polydrug users?

    InconclusivoEnsaio ClínicoEfeitos Adversos da CannabisAnsiedadeDepressão+1
  96. 2008

    JunD Is Involved In The Antiproliferative Effect Of Δ9-tetrahydrocannabinol On Human Breast Cancer Cells

    FavorávelEstudo LaboratorialCâncerCâncer — Mama
  97. 2008

    Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers

    InconclusivoEnsaio Clínico Duplo-CegoDorDor — AgudaQueimadura SolarTetraidrocanabinol (THC)
  98. 2008

    Lack of association of genetic variants in genes of the endocannabinoid system with anorexia nervosa

  99. 2008

    Linalool in Essential Plant Oils: Pharmacological Effects

    FavorávelMetanáliseDorInflamação
  100. 2008

    Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells.

    FavorávelEstudo LaboratorialCâncerCâncer — Mama